Hemodynamic Effects of Methylene Blue vs Hydroxocobalamin in Patients at Risk of Vasoplegia During Cardiac Surgery

NCT03446599 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Vasoplegia
Hypotension
Coronary Artery Disease
Cardiac Valve Disease

Interventions

DRUG: Hydroxocobalamin
DRUG: Methylene Blue
DRUG: Normal saline

Sponsor

Dartmouth-Hitchcock Medical Center